We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

49 hedge funds and large institutions have $9.37M invested in Fortress Biotech in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 49 → 49 (0)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

0.08% less ownership

Funds ownership: 0.71% → 0.63% (-0.08%)

21% less capital invested

Capital invested by funds: $11.9M → $9.37M (-$2.52M)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
49
Holders Change
–
Holders Change %
0%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
12
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.44M
2
Millennium Management
Millennium Management
New York
+$1.24M
3
PP
Paloma Partners
Connecticut
+$281K
4
FIA
FNY Investment Advisers
New York
+$231K
5
Jane Street
Jane Street
New York
+$226K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.44M
2
State Street
State Street
Massachusetts
-$823K
3
SO
STRS Ohio
Ohio
-$476K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$243K
5
Charles Schwab
Charles Schwab
California
-$135K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.17M +$1.44M +55,901 +66%
Millennium Management
2
Millennium Management
New York
$1.09M +$1.24M +48,360 New
BlackRock
3
BlackRock
New York
$643K -$2.44M -94,830 -77%
Northern Trust
4
Northern Trust
Illinois
$640K -$35.2K -1,369 -5%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$534K -$243K -9,433 -28%
OPPM
6
Opus Point Partners Management
New York
$351K – – –
Acadian Asset Management
7
Acadian Asset Management
Massachusetts
$329K +$113K +4,409 +43%
CL
8
CPWM LLC
Washington
$287K – – –
PP
9
Paloma Partners
Connecticut
$246K +$281K +10,940 New
FIA
10
FNY Investment Advisers
New York
$202K +$231K +8,984 New
Jane Street
11
Jane Street
New York
$197K +$226K +8,769 New
Jacobs Levy Equity Management
12
Jacobs Levy Equity Management
New Jersey
$189K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$188K – – –
Macquarie Group
14
Macquarie Group
Australia
$167K +$190K +7,406 New
State Street
15
State Street
Massachusetts
$136K -$823K -31,987 -84%
HAG
16
HighPoint Advisor Group
Illinois
$101K -$35.2K -1,369 -91%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$96K -$47.5K -1,849 -30%
WAM
18
Weiss Asset Management
Massachusetts
$91K +$104K +4,027 New
BRWA
19
B. Riley Wealth Advisors
Florida
$85K -$1.9K -74 -2%
Morgan Stanley
20
Morgan Stanley
New York
$70K +$31.5K +1,224 +66%
PSG
21
Planning Solutions Group
Maryland
$69K – – –
ARTA
22
A.R.T. Advisors
New York
$56K +$64.5K +2,508 New
Bank of America
23
Bank of America
North Carolina
$54K +$45.6K +1,773 +299%
SAM
24
Shikiar Asset Management
New York
$49K – – –
HighTower Advisors
25
HighTower Advisors
Illinois
$47K – – –
1
2 3

FBIO Hedge Fund Activity: Q2 2019 in Review

49 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2019, worth a combined $9.37M — down 21% from $11.9M a quarter earlier.

Fund positioning in FBIO was balanced in Q2 2019: 15 funds opened new positions, 15 closed out, 7 added to existing stakes and 12 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.44M. The largest seller was BlackRock, cutting an estimated $2.44M.

  • 49 institutional investors held Fortress Biotech (FBIO) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $9.37M of Fortress Biotech stock for Q2 2019, down 21% quarter-over-quarter.
  • 15 funds opened new Fortress Biotech positions in Q2 2019 and 15 closed out, a net change of 0 holders.
  • The largest Fortress Biotech buyer in Q2 2019 was Vanguard Group, an estimated $1.44M added.
  • The largest Fortress Biotech seller in Q2 2019 was BlackRock, an estimated $2.44M sold.

Based on aggregated 13F filings for Q2 2019.